Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

801
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
801
Genetics of Speciation02:16

Genetics of Speciation

21.2K
Speciation is the evolutionary process resulting in the formation of new, distinct species—groups of reproductively isolated populations.
21.2K
What is Population Genetics?01:25

What is Population Genetics?

64.7K
A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.7K
What is Genetic Engineering?00:49

What is Genetic Engineering?

80.2K
Overview
80.2K
Animal Mitochondrial Genetics02:59

Animal Mitochondrial Genetics

9.2K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
9.2K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

258
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lessons learnt from moving an intensive care unit into a new hospital.

Journal of the Intensive Care Society·2025
Same author

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods: a Korean translation.

Ewha medical journal·2025
Same author

Communicating clearly about data sharing in genomics.

Human genomics·2025
Same author

Primary care providers' experience and satisfaction with personalised breast cancer screening risk communication: a descriptive cross-sectional study.

BMJ open·2025
Same author

Diversity and Inclusion Within Datasets in Heart Failure: A Systematic Review.

JACC. Advances·2025
Same author

Dopamine genetic risk scores and psychiatric symptoms: Interacting risk factors for impulse control behaviours in de novo Parkinson's disease.

Journal of neuropsychology·2025
Same journal

RETRACTION: "Differential Effects of AKT1(p.E17K) Expression on Human Mammary Luminal Epithelial and Myoepithelial Cells".

Human mutation·2026
Same journal

Diagnostic Yield of Genome Sequencing in an Iranian Exome-Negative Autosomal-Recessive Intellectual Disability Cohort.

Human mutation·2026
Same journal

Exploring the Functional Impact of Individual <i>DDX41</i> Variants With a Fast and Robust Cell-Based Method.

Human mutation·2026
Same journal

Modeling the Effects of Single Nucleotide Polymorphisms (SNPs) on the Structure and Function of the Human <i>RET</i> Gene: An In Silico Study.

Human mutation·2026
Same journal

Driver Mutation Subtypes Differentially Shape Immune Evasion Landscapes in Melanoma: An AI-Driven Inflammatory Pathway Model Implicating CCNE1.

Human mutation·2026
Same journal

Comment on "When the Outcome Contains the Exposure: Methodological Limits of a Genome-Wide Cross-Trait Analysis of Type 2 Diabetes and MASLD".

Human mutation·2026
See all related articles

Related Experiment Video

Updated: Feb 4, 2026

The ITS2 Database
16:17

The ITS2 Database

Published on: March 12, 2012

32.3K

Genetic database software as medical devices.

Adrian Thorogood1, Seydina B Touré1, Johan Ordish2

  • 1Centre of Genomics and Policy, McGill University, Montreal, Canada.

Human Mutation
|October 13, 2018
PubMed
Summary
This summary is machine-generated.

Genomic software can improve data access but requires clear medical device regulations to ensure patient safety. Navigating global rules is key for developers to balance innovation with user protection.

Keywords:
European UnionFDAdata sharinggenomicslawmedical devicepublic genetic variant databasesregulationsoftware

More Related Videos

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K
Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

20.5K

Related Experiment Videos

Last Updated: Feb 4, 2026

The ITS2 Database
16:17

The ITS2 Database

Published on: March 12, 2012

32.3K
Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.5K
Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding
10:43

Rapid and Low-cost Prototyping of Medical Devices Using 3D Printed Molds for Liquid Injection Molding

Published on: June 27, 2014

20.5K

Area of Science:

  • Genomic data interpretation
  • Medical device regulation
  • Software as a Medical Device (SaMD)

Background:

  • Genomic databases are increasingly accessible via software tools, democratizing genetic information.
  • Interactive tools offer variant classification updates, extending access beyond clinical settings.
  • Concerns exist regarding the reliability of genomic software outputs and potential patient harm.

Purpose of the Study:

  • To provide a primer on medical device regulations for genomic software in the US, Europe, and Canada.
  • To clarify criteria for classifying software as medical devices and determining risk.
  • To offer strategies for maximizing genomic software utility while mitigating user risks.

Main Methods:

  • Review of medical device regulations in key global markets (US, Europe, Canada).
  • Analysis of criteria for Software as a Medical Device (SaMD) classification.
  • Examination of risk classification frameworks for genomic software.
  • Discussion of legal and regulatory uncertainties for global software developers.

Main Results:

  • Genomic software, especially when providing variant classification, may fall under medical device regulations.
  • Global distribution and direct-to-lay-user access complicate regulatory compliance.
  • Uncertainty exists regarding the application of evolving medical device regulations to genetic software.

Conclusions:

  • Clear regulatory pathways are needed to ensure patient safety and foster innovation in genomic software.
  • Developers must understand and navigate international medical device regulations.
  • Strategies can balance the benefits of accessible genomic information with the need for user safety.